Chinese Journal of Cancerindexed by SCI

About the cover
About the cover

Nov. 2016; Volume 35 Issue 11

In November 2005, the first oncolytic virus, a genetically modified adenovirus, named H101 by Shanghai Sunway Biotech, gained regulatory approval from China's State Food and Drug Administration (SFDA) for the treatment of head and neck cancer.

Research Highlight
Treatment implications of posterior fossa ependymoma subgroups
Vijay Ramaswamy and Michael D. Taylor
[ Abstract  391]  [ PDF Full-text  514]   [ HTML Full-text  355]    Epub: 2016-11-22  doi: DOI: 10.1186/s40880-016-0155-6
Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
Wen-Fei Li, Lei Chen, Ying Sun and Jun Ma
[ Abstract  379]  [ PDF Full-text  543]   [ HTML Full-text  377]    Epub: 2016-11-21  doi: 10.1186/s40880-016-0157-4
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Xiufeng Pang and Mingyao Liu
[ Abstract  470]  [ PDF Full-text  610]   [ HTML Full-text  377]    Epub: 2016-10-28  doi: 10.1186/s40880-016-0154-7
What do oncologists need to know about biosimilar products?
Linda K. S. Leung, Kevin Mok, Calvin Liu and Stephen L. Chan
[ Abstract  936]  [ PDF Full-text  720]   [ HTML Full-text  290]    Epub: 2016-10-17  doi: 10.1186/s40880-016-0151-x
Original Article
Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study
Qian Zhao, Wen-Long Yu, Xin-Yuan Lu, Hui Dong, Yi-Jin Gu, Xia Sheng, Wen-Ming Cong and Meng-Chao Wu
[ Abstract  876]  [ PDF Full-text  732]   [ HTML Full-text  313]    Epub: 2016-8-24  doi: 10.1186/s40880-016-0146-7
Association of microRNA polymorphisms with the risk of head and neck squamous cell carcinoma in a Chinese population: a case–control study
Limin Miao, Lihua Wang, Longbiao Zhu, Jiangbo Du, Xun Zhu, Yuming Niu, Ruixia Wang, Zhibin Hu, Ning Chen, Hongbing Shen and Hongxia Ma
[ Abstract  538]  [ PDF Full-text  612]   [ HTML Full-text  477]    Epub: 2016-8-11  doi: 10.1186/s40880-016-0136-9
Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients
Chen-Yue Qian, Yi Zheng, Ying Wang, Juan Chen, Jun-Yan Liu, Hong-Hao Zhou, Ji-Ye Yin and Zhao-Qian Liu
[ Abstract  582]  [ PDF Full-text  716]   [ HTML Full-text  450]    Epub: 2016-9-2  doi: 10.1186/s40880-016-0145-8
A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients
Ya-Hui Yu, Wei-Xiong Xia, Jun-Li Shi, Wen-Juan Ma, Yong Li, Yan-Fang Ye, Hu Liang, Liang-Ru Ke, Xing Lv, Jing Yang, Yan-Qun Xiang and Xiang Guo
[ Abstract  963]  [ PDF Full-text  711]   [ HTML Full-text  396]    Epub: 2016-6-29  doi: 10.1186/s40880-016-0124-0
Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma
Lie-Qiang Liao, Hong-Hong Yan, Jun-Hao Mai, Wei-Wei Liu, Hao Li, Zhu-Ming Guo, Zong-Yuan Zeng and Xue-Kui Liu
[ Abstract  465]  [ PDF Full-text  494]   [ HTML Full-text  411]    Epub: 2016-10-17  doi: 10.1186/s40880-016-0153-8
Case Report
Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period
Fumio Asano, Keisuke Watanabe, Masaharu Shinkai, Yoshitaka Tei, Kei Mishina, Mikiko Tanabe, Hiroshi Ishii, Masahiro Shinoda, Tadasuke Shimokawaji, Makoto Kudo and Takeshi Kaneko
[ Abstract  665]  [ PDF Full-text  837]   [ HTML Full-text  700]    Epub: 2016-7-2  doi: 10.1186/s40880-016-0127-x

CJC Wechat 微信公众号



Editorial Manager

CJC adopts Editorial Manager to manage its submissions from Dec.18, 2014


Reference style for  

 Reference Manager

Editorial Manager





Advanced search


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China